Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2
F. Sun, P. Yan, Y. Xiao, H. Zhang, S. D. Shapiro, G. Xiao, Z. Qu
This study develops nanoPDLIM2, a PDLIM2-expressing nanoparticle, which enhances PD-1 blockade and chemotherapy efficacy in lung cancer by reactivating tumor immunity and reducing drug resistance.
bioRxiv · Jul 23, 2023Cancer Biology